| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Cash flow from operating activities: | ||||||
Net loss | ||||||
-411 | -5,607 | -2,510 | - | - | ||
Net loss | ||||||
- | - | - | -5,347 | -8,314 | ||
Income (loss) from discontinued operations | ||||||
- | - | - | 41 | -3,329 | ||
Income (loss) from continuing operations | ||||||
- | - | - | -5,388 | -4,985 | ||
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||
Equity-based compensation | ||||||
3,209 | 2,304 | 2,119 | 4,654 | 8,156 | ||
Depreciation | ||||||
2,107 | 2,163 | 1,728 | - | - | ||
Noncash lease expense | ||||||
413 | - | - | - | - | ||
Depreciation and amortization | ||||||
- | - | - | 1,170 | 575 | ||
Loss on disposal of fixed asset | ||||||
-11 | -88 | -5 | - | 20 | ||
Amortization of premium of marketable securities | ||||||
106 | 297 | 370 | 63 | - | ||
Provision for bad debt | ||||||
189 | 309 | 160 | 76 | 48 | ||
Deferred taxes | ||||||
-21 | 36 | -336 | 246 | - | ||
Fair value adjustment recorded upon issuance of Class D-2 preferred units | ||||||
- | - | - | 5,472 | - | ||
Equity loss in investee | ||||||
-777 | -935 | -524 | 0 | - | ||
Other | ||||||
-52 | -44 | 15 | - | - | ||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
839 | 1,970 | -214 | 2,322 | 1,779 | ||
Other current and long-term assets | ||||||
-374 | -91 | - | - | - | ||
Other current assets | ||||||
- | - | 1,537 | 381 | 163 | ||
Accounts payable | ||||||
-329 | 102 | -363 | 1,094 | 132 | ||
Taxes payable | ||||||
- | - | -124 | 124 | - | ||
Accrued liabilities | ||||||
- | - | 1,098 | -372 | 62 | ||
Income tax payable | ||||||
24 | - | - | - | - | ||
Accrued liabilities and other current liabilities | ||||||
264 | 533 | - | - | - | ||
Operating lease liabilities | ||||||
-409 | - | - | - | - | ||
Other current liabilities | ||||||
- | - | -2 | - | - | ||
Cash provided by continuing operations | ||||||
- | - | - | 4,436 | 2,026 | ||
Cash used in discontinued operations | ||||||
- | - | - | -31 | -2,995 | ||
Net cash provided by operating activities | ||||||
5,517 | -675 | 1,331 | 4,405 | -969 | ||
Cash flow from investing activities: | ||||||
Purchases of fixed assets | ||||||
1,182 | 2,322 | 2,895 | 3,788 | 2,100 | ||
Proceeds from disposal of fixed assets | ||||||
- | - | - | 10 | 70 | ||
Sale of marketable securities | ||||||
- | - | 3,781 | - | - | ||
Purchase of marketable securities | ||||||
52,077 | 24,187 | 11,659 | 39,017 | - | ||
Maturities of marketable securities | ||||||
24,350 | 27,969 | 11,185 | - | - | ||
Purchase of equipment contributed to Equity Method Investee | ||||||
137 | 510 | 2,461 | - | - | ||
Cash used in continuing operations | ||||||
- | - | - | - | -2,030 | ||
Cash used in discontinued operations | ||||||
- | - | - | - | -175 | ||
Net cash used in investing activities | ||||||
-29,046 | 950 | -2,049 | -42,795 | -2,205 | ||
Cash flow from financing activities: | ||||||
Proceeds from issuance of Class D-2 preferred units | ||||||
- | - | - | 26,980 | - | ||
Repurchase and retirement of Class D-1 preferred and Class D common units | ||||||
- | - | - | 11,977 | - | ||
Tax distribution to Class D common and preferred unitholders | ||||||
- | - | - | 1,253 | - | ||
Proceeds from exercise of stock options | ||||||
38 | 15 | 31 | - | - | ||
Proceeds from public offerings of common stock, net of issuance costs | ||||||
28,758 | - | - | 36,790 | - | ||
Cash distributed in split-off of Pharma business | ||||||
- | - | - | 159 | - | ||
Capital contributions | ||||||
- | - | - | - | 3,500 | ||
Distribution to Class D-1 preferred unitholder | ||||||
- | - | - | 4,592 | - | ||
Payment of public offering costs | ||||||
- | - | 801 | - | - | ||
Repurchases of capital stock | ||||||
21 | - | - | - | - | ||
Net cash (used in) provided by financing activities | ||||||
28,775 | 15 | -770 | 45,789 | 3,500 | ||
Effect of exchange rate changes on cash and cash equivalents | ||||||
-17 | -44 | - | - | - | ||
Net decrease in cash and cash equivalents | ||||||
5,229 | 246 | - | - | - | ||
Effect of exchange rate changes on cash and cash equivalents | ||||||
- | - | 81 | - | - | ||
Net decrease in cash | ||||||
- | - | -1,407 | - | - | ||
Net decrease in cash | ||||||
- | - | - | 7,399 | 326 | ||
Supplemental disclosures of cash flow information: | ||||||
Income taxes paid | ||||||
20 | 1 | 757 | 550 | - | ||
Supplemental disclosures of non-cash investing and financing activities: | ||||||
Recapitalization | ||||||
- | - | - | - | 34,530 | ||
Fixed assets included in accounts payable | ||||||
- | - | 1,014 | 1,173 | 17 | ||
Purchases of fixed assets in accounts payable | ||||||
557 | 85 | - | - | - | ||
Operating lease right-of-use assets obtained in exchange for lease liabilities | ||||||
110 | - | - | - | - | ||
Public offerings costs included in accounts payable | ||||||
129 | - | - | - | - | ||
Initial public offering costs included in accounts payable and accrued expenses | ||||||
- | - | - | 801 | - | ||